Organogenesis Holdings (ORGO) Revenue: 2017-2025
Historic Revenue for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $150.9 million.
- Organogenesis Holdings' Revenue rose 30.98% to $150.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $465.2 million, marking a year-over-year increase of 2.24%. This contributed to the annual value of $482.0 million for FY2024, which is 11.29% up from last year.
- Latest data reveals that Organogenesis Holdings reported Revenue of $150.9 million as of Q3 2025, which was up 49.36% from $101.0 million recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' Revenue ranged from a high of $150.9 million in Q3 2025 and a low of $86.7 million during Q1 2025.
- In the last 3 years, Organogenesis Holdings' Revenue had a median value of $110.0 million in 2024 and averaged $114.0 million.
- Its Revenue has fluctuated over the past 5 years, first soared by 78.65% in 2021, then dropped by 22.44% in 2025.
- Organogenesis Holdings' Revenue (Quarterly) stood at $127.9 million in 2021, then fell by 9.65% to $115.5 million in 2022, then decreased by 13.73% to $99.7 million in 2023, then increased by 27.10% to $126.7 million in 2024, then skyrocketed by 30.98% to $150.9 million in 2025.
- Its Revenue was $150.9 million in Q3 2025, compared to $101.0 million in Q2 2025 and $86.7 million in Q1 2025.